Worsening of thrombotic thrombocytopenic purpura symptoms associated with desmopressin administration

Thrombosis and Haemostasis

Volumn 92, Issue 4, 2004, Pages 886-887

  Overman, Michael ^a   Brass, Eric ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; METHYLPREDNISOLONE; VINCRISTINE; VON WILLEBRAND FACTOR; ARGIPRESSIN[1 DEAMINO];

ADULT; AGITATION; APHASIA; ARTICLE; CASE REPORT; CRYOPRECIPITATE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSARTHRIA; EYE COLOR; FEMALE; FEVER; HAND DISEASE; HEADACHE; HUMAN; HUMAN CELL; JAUNDICE; LABORATORY TEST; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REMISSION; SYMPTOMATOLOGY; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINE COLOR; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; RECURRENT DISEASE; TREATMENT FAILURE;

ADULT; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; PLATELET TRANSFUSION; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE; TREATMENT FAILURE;

EID: 6344287883     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614196     Document Type: Article

References (20)

1. Moake JL. Thrombotic microangiopathies. NEJM 2002; 347: 589-600.
2. Veyradier A, Obert B, Houllier A, et al. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001; 98: 1765-72.
3. McCarthy LJ, Danielson CF, Miraglia C, et al. Platelet transfusion and thrombotic thrombocytopenia purpura. Transfusion 2003; 43: 829-30.
4. Bell RW, Hayden BG, Paul MN, et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Clinical experience in 108 patients. NEJM 1991; 325: 398-403.
5. Lind SE. Thrombocytopenic purpura and platelet transfusion (letter). Ann Intern Med 1987; 106: 478.
6. Harkness DR, Byrnes JJ, Lian EC, et al. Hazard of platelet transfusion in thrombotic thrombocytopeoic purpura. JAMA 1981; 246: 1931-3.
7. Gordon LI, Kwaan HC, Rossi EC. Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy. Semin Hematol 1987; 24: 194-201.
8. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years. Blood 1997; 90: 2515-20.
9. Borchielline A, Fijnvandraat K, ten Cate JW, et al. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood 1996; 15: 2951-8.
10. Vischer UM, Ingerslev J, Wollhein CB, et al. Acute von Willebrand factor secretion from endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels. Thromb Haemost 1997; 77: 387-93.
11. Moake JL, Turner NA, Stathopouls NA, et al. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78: 1456-61.
12. Sakariassen, KS, Cattaneo M, Berg A, et al. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984; 64:229-36
13. Stratton J, Warwicker P, Watkins S, et al. Desmopressin may be hazardous in thrombotic microangiopathy. Nephrol Dial Transplant 2001; 16: 161-2.
14. Tsai H, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. NEJM 1998; 339: 1585-94.
15. Hartmann S, Reinhart W. Fatal complication of desmopressin. Lancet 1995; 345:1302-3
16. Byrnes JJ, Larcada A, Moake JL. Thrombosis following desmopressin for uremic bleeding. Am J Hem 1988; 28: 63-5.
17. Albert SG, Salvato-Lechner V, Joist JH. Venous thromboembolism and transient thrombocytopenia in a patient with diabetes insipidus treated with desmopressin acetate (DDAVP). Thrombosis Research 1988; 50: 695-705
18. Mannucci PM, Lusher JM. Desmopressin and thrombosis. Lancet 1989; 16: 675-6.
19. Flordal PA, Ljungstrom K, Fehrm A. Desmopressin and postoperative thromboembolism. Thrombosis Research 1992 68:429-33
20. Czer LSC, Bateman TM, Gray PJ, et al. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. J Am Cell Cardiol 1987; 9: 1139-47.